GlassScriptPhysician profile
Julien Vaisman
NPI 1366489312
$7,049.25
in general payments reported to CMS, 2019-2025
19 companies · $1,201 in 2025
The $1,201 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $208 · 2021: $216 · 2022: $3,929 · 2023: $540 · 2024: $544 · 2025: $1,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Travel and Lodging: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.46 |
| Travel and Lodging | $957.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,591.21 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Relievant Medsystems, INC. | $1,436.12 | 2022-2023 | Intracept |
| Spinal Simplicity, LLC | $1,030.13 | 2024-2025 | Ha Minuteman G3-R, Patriot Si |
| Abbott Laboratories | $308.54 | 2020-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $300.84 | 2020-2022 | |
| Nevro Corp. | $296.39 | 2019-2023 | Senza |
| Painteq LLC | $274.12 | 2024 | Painteq |
| Mml US, INC. | $201.22 | 2023 | Reactiv8 |
| Boston Scientific Corporation | $124.03 | 2022-2024 | Superion Indirect Decompression System, Intracept |
| Abbvie INC. | $123.98 | 2024-2025 | |
| Si-Bone, INC. | $79.91 | 2019-2025 | |
| Saluda Medical Americas, INC. | $58.63 | 2024 | Evoke |
| Vertos Medical, INC. | $58.00 | 2022-2023 | Mild Device Kit |
| Nalu Medical, INC. | $42.38 | 2025 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $38.66 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $37.32 | 2019 | |
| Amgen INC. | $30.83 | 2019 | |
| Allergan, INC. | $16.94 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julien Vaisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.